Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Alterations of CSF Protein Markers as Prognostic Indicator of the Response to Cerebrospinal Fluid Shunting in Chronic Hydrocephalus in Adults

NCT05915000 is registered in ClinicalTrials.gov with University of Valencia as lead sponsor.

NCT NCT05915000
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05915000 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Alterations of CSF Protein Markers as Prognostic Indicator of the Response to Cerebrospinal Fluid Shunting in Chronic Hydrocephalus in Adults
Lead sponsor
University of Valencia
Phase
Observational
Overall status
Recruiting
Start date
June 13, 2019
Completion date
December 31, 2029
Enrollment
150 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

beta-amiloid and phospho-tau proteins in csf, cognitive impairment and csf shunt, motor impairment evolution after csf shunt, ventricular size after csf shunt